CA
NZ
UK
AU
IND
US
FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in National Vision Holdings Inc. as of an event date of October 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 667,465 shares of Gossamer Bio Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 3 to a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Hillman Solutions Corp as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 7 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of Class A Common Stock in UWM Holdings Corp as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 37,861,566 shares of common stock in MiniMed Group Inc., representing 13.5% of the class, as of an event date of October 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 3,250,000 shares of Aspen Neuroscience Inc. common stock as of October 30, 2026.
FMR LLC filed an amended Schedule 13G with the SEC on November 5, 2026, disclosing a 15.0% beneficial ownership position in Tango Therapeutics Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 2 to Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 9,514,519 shares of Strive Inc Class A Common Stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 4 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Sprouts Farmers Market Inc. as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of common stock in City Therapeutics Inc. as of October 30, 2026.
Please wait processing your request...